XI
GMED icon

XXEC Inc’s Globus Medical GMED Stock Holding History

XXEC Inc’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-48,800
Closed -$3.62M – 26
2022
Q4 		$3.62M Sell
48,800
-1,025
-2% -$69.8K 2.91% 18
2022
Q3 		$2.97M Sell
49,825
-800
-2% -$48.2K 2.55% 19
2022
Q2 		$2.84M Sell
50,625
-1,150
-2% -$75.6K 2.26% 19
2022
Q1 		$3.93M Sell
51,775
-150
-0.3% -$10.4K 2.74% 19
2021
Q4 		$3.42M Hold
51,925
– – 2.92% 15
2021
Q3 		$3.98M Sell
51,925
-6
-0% -$482 3.03% 15
2021
Q2 		$4.03M Sell
51,931
-869
-2% -$61.8K 2.66% 16
2021
Q1 		$3.26M Hold
52,800
– – 2.29% 19
2020
Q4 		$3.44M Buy
52,800
+2,800
+6% +$161K 2.71% 16
2020
Q3 		$2.75M Buy
+50,000
New +$2.58M 2.62% 14

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

XXEC Inc's GMED Position: Q1 2023 in Review

XXEC Inc sold out of Globus Medical (GMED) in Q1 2023, closing a stake of 48,800 shares — an estimated $3.62M sold.

XXEC Inc first reported a position in GMED in Q3 2020 and held it in 10 quarters. The position peaked at $4.03M in Q2 2021. 390 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

  • XXEC Inc reported no remaining Globus Medical position as of Q1 2023 after selling out during the quarter.
  • XXEC Inc sold 48,800 Globus Medical shares in Q1 2023, an estimated $3.62M.
  • XXEC Inc first reported a position in Globus Medical in Q3 2020 and held it in 10 quarters.
  • XXEC Inc's Globus Medical position peaked at $4.03M in Q2 2021.
  • 390 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on XXEC Inc's 13F filing for Q1 2023, filed 8 May 2023.